TABLE A5.
EORTC QLQ-BN20 Score Changes Compared With the Baseline
| Category | Visit | Total (N = 60) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| No. | Mean | SD | Q1 | Median | Q3 | Minimum | Maximum | ||
| Total score | Cycle 3 – cycle 1 | 53 | –5.66 | 11.64 | –13 | –2 | 1 | –32 | 26 |
| Cycle 5 – cycle 1 | 47 | –7.89 | 12.43 | –17 | –8 | 1 | –39 | 15 | |
| Cycle 7 – cycle 1 | 42 | –6.45 | 11.81 | –14 | –3 | 1 | –40 | 11 | |
| Cycle 9 – cycle 1 | 14 | –12.57 | 12.20 | –20 | –13 | –5 | –40 | 11 | |
| Cycle 11 – cycle 1 | 9 | –10.33 | 13.72 | –12 | –11 | –8 | –38 | 12 | |
| Cycle 13 – cycle 1 | 5 | –8.80 | 7.92 | –14 | –11 | –7 | –16 | 4 | |
| Cycle 15 – cycle 1 | 2 | –9.00 | 5.66 | –13 | –9 | –5 | –13 | –5 | |
| EOT – cycle 1 | 15 | 2.80 | 13.45 | –2 | 1 | 10 | –25 | 38 | |
Abbreviations: EORTC QLQ-BN20, 20-item EORTC Quality of Life Questionnaire–Brain Neoplasm questionnaire; EOT, end of treatment; Q1, 1st quartile; Q3, 3rd quartile; SD, standard deviation.